Актуальность и опыт более чем 40-летнего применения диметиндена малеата: обзор проведенных клинических исследований

1. Barrett WE et al. A pharmacologic investigation of dimethpyrindene maleate (Forhistal®). Toxicol Appl Pharmacol 1961; 3: 534–44.
2. Reinhardt D et al. H1-Receptor antagonists: comparative pharmacology and clinical use. Klin Wochenschr 1982; 60: 983–90.
3. Lau HYA et al. Dual effect of antihistamines on rat peritoneal mast cells: induction and inhibition of histamine release. Agents Actions 1985; 16: 176–8.
4. Liu WL et al. Inhibitory effect of the stereoisomers of dimethindene maleate (Fenistil®) on histamine release from rat peritoneal mast cells. Agents Actions Special Conference Issue 1992; p. 302–4.
5. Wexler L. A clinical evaluation of dimethindene. Curr Ther Res 1962; 4: 306–9.
6. Morimoto S et al. Comparative study on some pharmacological actions of 2-(1-[2- Dimethylaminoethyl)-3-indenyl] ethyl) pyridine Maleate (Dimethpyrindene maleate) and Chloropeniramine maleate. J Osaka City Med Center 1965; 14: 19–30.
7. Plummer AJ et al. Forhistal: experimental data. Report, 1960.
8. Leuschner F. Uber pharmakologische Eigenschaften von Dimethpyrinden (On pharmacological properties of Dimethpyrindene). Report 0–10, 1972.
9. Galli A. Pharmacological assessment. Study of the antihistamine properties of Fenistil gel. Report, 1977.
10. Bibi H et al. Dimethpyrindene maleate in the treatment of recurrent spasmodic croup; Drugs Exptl Clin Res 1984; 10: 141–5.
11. Schaffler K et al. Study to evaluate the anesthetic activity of local dimethindene maleate vs lidocaine and placebo using quantitative/objective algesimetry (LASER-SEPs) in healthy volunteers. Report, 1991.
12. Schaffler K et al. Evaluation of the local anaesthetic activity of dimethindene maleate by means of laser algesimetry in healthy volunteers. Arzneim Forsch/Drug Res 1992; 42 (2): 1332–5.
13. Rehn D et al. Effect-kinetic characterization of dimethindene maleate following oral administration (Fenistil, Tropfen). Fundam Clin Pharmacol 1990; 4: 673–83.
14. Rehn D et al. Time course of the effect of intravenouse dimethindene maleate. Eur J Clin Pharmacol 1990; 39: 137–41.
15. Witte PU et al. Investigation of the long-term tolerance and efficacy of dimethindene maleate (Fenistil 4 mg once a day, FOAD). Report, 1995.
16. Niederle J. A multicentre, randomised, open parallel, comparative study of the antipruritic effect and tolerability of Fenistil (dimethindene maleate) drops and Teldane (terfenadine) suspension in children with chickenpox (varicella). Report, 1990.
17. Bauer C-P. Dimetindenmaleat in der Behandlung des Juckreizes bei Windpocken (Dimethindene maleate in the treatment of itching in chickenpox). Der Kinderarzt 1997; 28: 1–3.
18. Bauer C-P. Efficacy and tolerability of dimethindene maleate solution (DMM; Fenistil drops) in two different concentrations vs. placebo in children suffering from chicken-pox. Report, 1997.
19. Englisch W et al. Dimethindene maleate in the treatment of pruritus caused by Varizella zoster virus infection in children; Arzneim-Forsch/Drug Res 1997; 47 (11): 1233–5.
20. Morsbach P. Behandlungsergebnisse mit dem Antihistaminikum Fenistil (Treatment results of the antihistamine Fenistil). Praxis 1962; 51: 232–6.
21. Balda H et al. Efficacy and tolerance of dimethindene maleate pellets (DMM, Fenistil-OAD) vs placebo in patients with a body mass between 35 kg and 43 kg suffering from seasonal allergic rhinitis. Report, 1998.
22. Huckauf H et al. Evaluation of a protective effect of dimethindene maleate (Fenistil drops) following a histamine-induced broncho-constriction in volunteers with bronchial hyperreactivity. Report, 1994.
23. Lorenz W et al. Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and antihistamines after induction of anaesthesia. Lancet 1992; 343: 933–40.
24. Mutschler E et al. Chapter 2.9: Tissue hormons, in: Drug Actions – Basic Principles And Therapeutic Aspects. Medpharm, CRC Press Boca Raton, Ann Arbor, Boston, 1995.
25. Petruzzellis V. Employ of Fenistil once-a-day (=FOAD), sustained-release 4 mg capsules, in the treatment of itching in patients with eczema. Double-blind controlled study versus the active drug. Report, 1990.
26. Mesquita-Guimaraes J et al. Dimethindene versusastemizole in the treatment of itching ec- zematous disorders: a randomized, double-blind, comparative trial. Eur J Dermatol 1994; 4: 202–6.
27. Bhatt AD et al. Comparative Effect of dimethindene maleate and chlopheniramine maleate on histamine-induced weal and flare. J Int Med Res 1991; 19: 479–83.
28. Simpson-Laing J. Fenostil retard in pruritus. A double-blind compara­tive trial with sustained release chlorpheniramine maleate in general practice. Report, 1985.
29. Poisson A et al. Essai en simple insu d'un nouvel antihistaminique: Le maleate de dimetindene dans la pollinose (Assay on a simple unknown new antihistaminine: Dimethindene maleate in pollinosis). Gaz Med Fr 1984; 91: 65–70.
30. Kiehn R et al. Fenistil-Retard versus Hismanal bei Patienten mit chronisch-juckenden Dermatosen (Fenistil retard vs. Hismanal by patients with chronic itching dermatoses). Allergol 1987; 11: 512–5.

Т.Добмейер

Фрейдрихсдорф